—TPR
— • —
$149.89
P/E
61.85
PEG
—
FCF Yield
—
Rev Growth YoY
+1090.0% YoY
Gross Margin
7598.0%
Health Score
4/10
D/E Ratio
2.79
Confidence
LOW
Business Snapshot
The ticker and exchange identifiers are absent from this payload, which limits contextual framing. Based on the available financial data — including a current price of $149.89, a P/E of 61.85x, and a Price/Sales of 4.05x — this appears to be an operationally active company with significant recent revenue growth. The absence of a reported market capitalisation prevents a definitive cap-tier classification, though the valuation ratios suggest a company of meaningful but uncertain scale.
Financial Health
**Score: 4/10** The company's reported gross margin of 7,598% and net margin of 695% are extraordinary figures that are almost certainly the result of a small base-year distortion or accounting anomaly rather than genuine operational efficiency — investors should treat these numbers with significant scepticism. On the debt side, a Debt/Equity ratio of 2.79x signals a highly leveraged balance sheet, which elevates financial risk particularly if cash flow conditions tighten...
Risk Assessment
- **VALUATION: P/E of 61.85x is approximately 2.5x the sector average of 25x, leaving the stock highly exposed to multiple compression if growth disappoints.** - **DEBT: Debt/Equity of 2.79x indicates a heavily leveraged balance sheet, creating refinancing and interest-burden risk.** - **EARNINGS QUALITY: Earnings growth of -2,968% YoY directly contradicts the headline revenue surge of +1,090%, suggesting the growth is not translating into profitability.** - **DATA GAPS: Free cash flow, TTM Revenue, TTM Net Income, and DCF fair value are all unavailable, making a full fundamental assessment impossible.** - **TECHNICAL DETERIORATION: A confirmed death cross (50-day MA crossing below the 200-day MA) alongside a bearish MACD signal indicates negative price momentum on both medium and longer-term horizons.** ---...